Facebook Instagram Linkedin Youtube
Home Tags RVO

Tag: RVO

Annexin_Pharmaceuticals

Annexin Pharmaceuticals: Could ANXV replace anti-VEGFs?

Annexin Q1 2024

Annexin towards completion of phase II study and share issue

Annexin CSO interview

Annexin’s CSO on progress in cancer initiative

Annexin framgång RVO

Annexin’s CEO: “Our biggest success in a long time”

Annexin imagingdata

Annexin’s CMO on study results and participation in ARVO

Susanne Andersson CFO Annexin Pharmaceuticals

One-on-one with Annexin Pharmaceuticals’ new CFO

Annexin Q4 2022

Intense Q4 leads Annexin into interesting 2023

Annexin cancer shares issue

Annexin’s CEO: “The cancer area more than doubles the potential”

Annexin Q3 2022

Annexin updates in conjunction with the Q3 report

Phase II focus and further potential in Annexin´s Q2

12Page 1 of 2
© BioStock 2024